Pricing and reimbursement for Biosimilars

Pricing and reimbursement considerations for Biosimilars


Paul Craddy is proud to be presenting ‘Pricing and reimbursement considerations for Biosimilars’ at the Global Pharmaceutical Regulatory Affairs Summit at the Clarion Congress Hotel in Prague tomorrow (24 Oct)

Read our presentation here Biosimilar 2017 Prague 231017 1_0.

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.